Clinical Trial Kits Market Size To Reach $3.87 Billion By 2033

Clinical Trial Kits Market Growth & Trends

The global clinical trial kits market size is expected to reach USD 3.87 billion by 2033, registering a CAGR of 9.05% from 2026 to 2033, according to a new report by Grand View Research, Inc. The factors driving market expansion include globalization of clinical trials, increasing demand for remote services, and rising clinical trial complexity.

Remote clinical trial services are becoming increasingly essential in terms of patient retention, satisfaction, and safety. To enhance their capabilities, pharmaceutical companies have created a relationship with global logistics partners to provide direct-to-patient services. These services provide participants with the flexibility and convenience of participating in the trials while remaining at home.

COVID-19 pandemic has affected the market which resulted in slowing down the trial process. The COVID-19 pandemic is rapidly boosting advances in medical practices that allow people to connect with the healthcare system remotely. This effort of examining the patients at their homes has raised interest in at-home sample collection and testing. Such services offer convenience and minimize potential exposure to SARS-CoV-2.

Companies began to move to provide direct-to-consumer testing digital services. More aspects of the testing process, from test ordering to sample collection, are already making their way into patients' homes. Besides, regulatory authorities have instantly given sponsors guidelines to resolve issues that have arisen during ongoing clinical studies. Changes such as the use of telemedicine, the elimination of non-essential visits and laboratory assessments, as well as diagnostic testing and sample collection, have allowed many studies to continue while ensuring patient safety during the pandemic.

 Request a free sample copy or view report summary: Clinical Trial Kits Market Report

Clinical Trial Kits Market Report Highlights

• Based on service, the logistics segment held the largest market share of 56.40% in 2025. The kitting solutions segment is expected to witness the fastest growth.

• Based on phase, phase III held the largest market share in 2025. Phase I is expected to grow at the fastest rate during the forecast period.

• Based on application, the small molecule trials segment held the highest market share in 2025. The large molecule trials segment is expected to experience the fastest growth rate during the forecast period.

• Based on the end-use, the pharmaceutical & biopharmaceutical companies segment dominated the industry in 2025.

• North America clinical trial kits market held the largest share of 43.52% of the global market in 2025. The clinical trial kits in the U.S. are expected to grow significantly over the forecast period.

• The clinical trial kits market in Asia Pacific is projected to grow at the highest CAGR over the forecast period.

Clinical Trial Kits Market Segmentation

Grand View Research has segmented global clinical trial kits market based on service, phase, application, end-use, and region:

Clinical Trial Kits Service Outlook (Revenue, USD Million, 2021 - 2033)

• Kitting Solutions

  • Drug Kits

  • Sample Collection Kits

  • Self-Therapy Kits

  • Medical Device Trial Kits

  • Cell Therapy-Specific Kits

  • Others

• Logistics

  • Transportation

  • Warehousing & Storage

  • Others

Clinical Trial Kits Phase Outlook (Revenue, USD Million, 2021 - 2033)

• Phase I

• Phase II

• Phase III

• Phase IV

Clinical Trial Kits Application Outlook (Revenue, USD Million, 2021 - 2033)

• Small Molecule Trials

• Large Molecule Trials

  • Biologics

  • Cell Therapy

  • Gene Therapy

  • Other

• Medical Device Trials

End-use Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical & Biopharmaceutical Companies

• Contract Service Providers (CRO/CDMO)

• Others

Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Oman

  • Qatar

List of Key Players of Clinical Trial Kits Market

• Brooks Life Sciences (Azenta, Inc.)

• Patheon (Thermo Fisher Scientific, Inc.)

• Labcorp Drug Development

• Charles River Laboratories

• LabConnect

• Almac group

• Precision Medicine Group, LLC.

• Cerba Research

• Diploma PLC (Alpha Laboratories)

• United Parcel Service (Marken)

• Clinigen